PubMed Health⌕ Search

Biomedical subjects

D Luehmann

Publications and source records attributed to D Luehmann.

8 recordsLinked to original sources

Technical requirements for rapid high-efficiency therapies.

Significant reductions in treatment time are possible with rapid high-efficiency hemodialysis and hemodiafiltration, provided the therapies are implemented so as to maintain adequacy of solute and fluid removal without compromising patient comfort. The key technical elements necessary for such implementation include high blood flow rates, higher efficiency dialyzers/diafilters, ultrafiltration control systems, and bicarbonate as the buffer source. In addition, hemodiafiltration requires schemes to ensure sterility and nonpyrogenicity of the infusion fluid and appropriate balancing of the rates of ultrafiltration and reinfusion. In general, rapid high-efficiency therapies are technically more complex than standard therapy, and rapid hemodiafiltration appears to be more complex than rapid hemodialysis. The technology required for rapid hemodialysis currently exists, but it needs to be fine-tuned and integrated for routine application.

Acetates↗

Peracetic acid for reuse of hemodialyzers clinical studies.

When Renalin was used for reprocessing, the incidences of headache and hypotension were reduced and no changes in serum chemistries were noted. Dialyzer appearance was superior to that achieved with formaldehyde but accompanied by decreases in clearance of urea, creatinine, vitamin B-12 and a fall in KUF. While long-term patient toxicity studies are not yet available, laboratory studies suggest potential problems with carcinogenicity similar to those erroneously attributed to formaldehyde. These data suggest that Renalin may be a suitable alternative to formaldehyde for reprocessing hemodialyzers.

Acetates↗